Nasdaq told Quince Therapeutics its stockholders' equity was ($35,324,000), below the $10,000,000 minimum. The company has until October 15, 2026 to submit a compliance plan and has filed an initial listing application that would come with a name change.
Quince Therapeutics agreed to sell about $11.5 million of stock and warrants to institutional investors and three executives, and up to $10.4 million more depends on holders paying $1.20 per share.
Questions about IRulya Therapeutics
What is the ticker symbol of IRulya Therapeutics?
IRulya Therapeutics Inc. trades under the ticker QNCX on NASDAQ.
Where is IRulya Therapeutics listed?
IRulya Therapeutics Inc. is listed on NASDAQ.
Which country or territory is IRulya Therapeutics listed under?
Our directory records IRulya Therapeutics Inc. under Not recorded.
Does aibio.space cover IRulya Therapeutics?
aibio.space lists IRulya Therapeutics Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Which other companies' news mentions IRulya Therapeutics?
IRulya Therapeutics is named in 2 of our stories about other companies, most recently: "Quince Therapeutics (now IRulya Therapeutics) gets Nasdaq stockholders' equity deficiency notice" (Sep 4, 2026); "Quince Therapeutics (now IRulya) agrees to $11.5 million private placement" (Jun 13, 2025). Source.
How can I follow IRulya Therapeutics (QNCX) news?
Press Follow on this page to add IRulya Therapeutics to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming IRulya Therapeutics so far, in Financings, Listings.
Investor discussion: IRulya Therapeutics
Members talk about IRulya Therapeutics (QNCX). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:QNCX on TradingView.
Listing details
IRulya Therapeutics Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker QNCX, recorded under Not recorded. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Company
IRulya Therapeutics Inc.
Ticker
QNCX
Listing
NASDAQ
Country or territory
Not recorded
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio